The Science & PINS Prize for Neuromodulation is a highly competitive prize which honors scientists for their excellent contributions to neuromodulation research.
About the Prize
The Science & PINS Prize for Neuromodulation is a highly competitive prize which honors scientists for their excellent contributions to neuromodulation research. Neuromodulation is any form of alteration of nerve activity through the delivery of physical (electrical, magnetic, optical) stimulation or chemical agents to targeted sites of the body. Established in 2016, the prize is awarded annually for outstanding research as described in a 1,500 word essay based on research performed in the past three years.
The winner of the Science & PINS Prize for Neuromodulation is awarded US$25,000 and publication of his or her essay in Science. The Grand Prize essay and that of the Runner-up are also published on Science Online. The award is announced and presented at a ceremony in September 2017. PINS will provide financial support to help enable the grand prize winner to attend the ceremony.
The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society, and publisher of the journals, Science, Science Translational Medicine, Science Signaling, Science Advances, Science Immunology, and Science Robotics. AAAS was founded in 1848, and includes some 254 affiliated societies and academies of science, serving 10 million individuals. Science, founded by Thomas Edison, has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of more than 400,000.
The non-profit AAAS—www.aaas.org—is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy, international programs, science education, and more. Science's daily online news is always free to the public, as are editorials, any paper with broad public health significance, and all research articles 12 months after publication. Science further participates in various efforts to provide free access for scientists in the world's poorest countries.
Beijing PINS Medical Equipment Co. Ltd. was established in 2008 and is located in Changpin Garden, Zhongguancun Science and Technology Park, Beijing, China. As an innovative high-tech enterprise with focus on neuromodulation, a variety of clinical products have been developed to date, which include stimulators for deep brain, vagus nerve, spinal cord and sacral nerve stimulation therapies. PINS Medical devotes itself to providing cutting edge treatments for patients who suffer from neurological disorders such as Parkinson’s disease, epilepsy, chronic pain and uroclepsia.
As part of the “National Engineering Laboratory for neuromodulation”, PINS Medical works in close cooperation with Tsinghua University and the numerous affiliated clinical centers, becoming a center of attraction for a wide range of professional talents in areas of clinical research, innovative R&D and business management. Since 2008, PINS Medical has developed rapidly in becoming a leading brand in neuromodulation within the Chinese market, due to the success of its creative research platform that efficiency links basic research, R&D of novel products, clinical testing and market entry.
With an outstanding reputation as a high-tech healthcare corporation, PINS Medical has a primary mission for providing innovative, high-quality products and services for patients to improve quality of life.
The name of PINS is derived from a Chinese word with the original meaning of “Magic Pin”, the ability to cure every disease. PINS is also an abbreviation of “Patient Is No.1 always”. This clearly presents the goal of PINS Medical for “restoring hope”, not simply as an innovation company but also across society to citizens.
Looking into the future with the continuous rise in incidence of neuropsychiatric disorders and increased social burden across the globe, PINS Medical along with local government, research centers, companies and top academic scientists, are now developing innovative therapies through innovative research projects.